Skip to main content
Free expedited shipping on all orders

Low libido in women: causes, myths, and real options

4 min read 6 sources
Jillian Foglesong Stabile, MD

Jillian Foglesong Stabile, MD, FAAFP, DABOM

Sipra Medical Reviewer

  • American Board of Family Medicine
  • American Board of Obesity Medicine
  • Wake Forest University School of Medicine

ReviewsPatient-facing health education

VerifyNPI registryDoximityLinkedInHealthline

Board-certified Family Medicine · Diplomate, ABOM · Medical reviewer of record · Updated Sep 16, 2026

You used to want sex. Now the thought barely registers, and a small voice keeps asking what is wrong with you. Maybe a partner has noticed. Maybe you have started avoiding the conversation entirely. Here is the first thing worth saying plainly: low desire in women is common, it is rarely a character flaw, and it usually has a cause you can actually name. So let's name the real ones, clear out the myths, and walk through the options that have evidence behind them.

The short version: Low libido in women usually comes from a mix of causes: hormones, sleep, mood, stress, relationship strain, and certain medications. It is treatable. Real options range from addressing the root cause to two FDA-approved prescription treatments for one specific diagnosis. A clinician helps match the option to the cause. Individual results vary.

What you will learn
  • The real causes of low desire, from hormones to medications to stress
  • The myths that make women feel broken when they are not
  • What HSDD actually is, and the two FDA-approved treatments for it
  • Where testosterone fits, and why the "no approved product" point matters
In this guide

Low desire is a symptom, not a verdict

Low libido is best understood as a signal, not a flaw. Desire in women is driven by many inputs at once: hormone shifts, sleep, mood, stress, relationship context, and side effects from common medications. When desire drops, one of those inputs has usually changed. The fix starts with finding which one.

In this guide

The myths do real damage

A handful of stubborn myths keep women silent and untreated. They sound like common sense. They are wrong, and they cost women years of needless self-blame. Naming them is the fastest way to stop letting them run the show.

In this guide

What actually helps, from root cause to prescription

The best treatment depends entirely on the cause. For most women, the highest-value move is fixing the thing underneath: treating pain, protecting sleep, reviewing a medication, or repairing connection. For one specific diagnosis, called HSDD, there are also FDA-approved medicines. Let's go in that order.

OptionBest suited forFormWorth knowing
Treat the root causeMost women (pain, sleep, mood, meds, stress)VariesHighest-value first step; fixes the input that changed
Review a medication with your prescriberDesire drop after starting an SSRI or other drugConversationNever stop a prescription on your own; ask about alternatives
Flibanserin (Addyi)Acquired, generalized HSDD in women under 65, with label exclusionsDaily pillFDA-approved; clinician reviews contraindications and interactions
Bremelanotide (Vyleesi / PT-141)Premenopausal acquired, generalized HSDD with label exclusionsOn-demand self-injectionClinician reviews contraindications and risks
Local treatment for painful sexWhen dryness or pain is the driverCream, ring, tablet, OTC moisturizersPain quietly kills desire; treating it can restore it
Testosterone (off-label)Some postmenopausal women, physician-ledDosed-down male formulationNo FDA-approved female product; monitored trial only, per 2019 consensus
Counseling / sex therapyPsychological, relationship or distress concernsTalk therapyAn option to discuss; suitability and evidence vary by approach
Safety note

HSDD stands for hypoactive sexual desire disorder. It describes persistently low sexual desire that causes personal distress and is not better explained by another cause. It is a clinical diagnosis a physician makes, not a label you give yourself. For HSDD specifically, two prescription treatments are FDA-approved.

Safety note

This is the part the internet gets wrong most often, so read it carefully. There is no FDA-approved testosterone product for women. None. Any use of testosterone for female desire is off-label and a matter of physician judgment, not a routine prescription you should expect to be handed.

Clear health guidance, in your inbox.

In this guide

How to get evaluated with dignity

That last point is where a lot of care quietly fails. The first conversation is the easy part. The follow-up, the dose check-in, the "this is not working, what now," is where real relief is won or lost. So this is a fair standard to apply to any online provider you consider. A good women's health provider shows you the full cost up front: the consultation fee, the medication cost, any lab cost, and the cancellation policy, and no surprise charges later. If a brand cannot tell you all of those numbers plainly, that tells you something.

In this guide

Your next three steps

Name what changed. Jot down when your desire shifted and what else changed around then: sleep, a new medication, stress, pain, your cycle.

Your hormones deserve better than guesswork

  • Online visits with licensed physicians
  • Estradiol, progesterone, HRT & sexual wellness
  • Lab panels at member pricing
  • FSA & HSA eligible with all plans
A smiling woman with dark hair in a cream sweater
From$65/mo

From price shown is the 12-month plan rate. Prices may vary.

Frequently asked questions

Was this helpful?

Keep reading

Sources

  1. FDA. Vyleesi prescribing information, 2020. Indication and contraindications. accessdata.fda.gov
  2. ACOG. "Treatment of Urogenital Symptoms in Individuals With a History of Estrogen-dependent Breast Cancer." December 2021. acog.org
  3. Cleveland Clinic. "Perimenopause: Age, Stages, Signs, Symptoms & Treatment." Accessed 2026. my.clevelandclinic.org
  4. npj Women's Health. "Perimenopause symptoms, severity, and healthcare seeking in women in the US." 2025. nature.com
  5. FDA. Addyi prescribing information, December 2025. accessdata.fda.gov
  6. Global Consensus Position Statement on the Use of Testosterone Therapy for Women (2019). tandfonline.com